Communication in Serious Illness
Target audience: healthcare teams such as physicians, nurses, social workers and other healthcare providers.
This 2.5-hour didactic session objective is to review the need for a systematic approach to having more, better and earlier conversations about patient values and priorities in serious illness; define a population with serious illness who may benefit from the serious illness conversation and learn how to improve communication with patients who have a serious illness with a structured
communication tool. During this highly interactive workshop participants will have the opportunity to practice case study conversations.
Registration is free but space is limited. Register Here
If you have any questions, please contact Karen Beckford at 602-445-4312, email
Acknowledgment: This CME event is not supported by any commercial entity.
Disclosure: Tania Bahti discloses she is a consultant for Relias Learning and the owner of Pathways-Education in End of Life Care. All other speakers and members of the planning committee have no relevant financial relationships with a commercial interest to disclose.
Accreditation Statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Arizona Medical Association (ArMA) through the joint sponsorship of HonorHealth and AZHHA. HonorHealth is accredited by the Arizona Medical Association (ArMA) to provide continuing medical education for physicians.
Credit Statement: HonorHealth designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
You must request your CME Certificate after the training by emailing your name and title (MD, DO, etc..) to cme@honorhealth.com.
- July 24, 2018 at 6pm – 8:30pm
-
Arizona Hospital and Healthcare Association
2800 N Central Ave
Suite 1450
Phoenix, AZ 85004
United States
Google map and directions -
Karen Beckford
602-445-4312
Be the first to comment
Sign in with
Facebook Twitter